|
Volumn 3, Issue 10, 2011, Pages 1049-1055
|
LC- and CZE-ICP-MS approaches for the in vivo analysis of the anticancer drug candidate sodium trans-[tetrachloridobis(1H-indazole)ruthenate(iii)] (KP1339) in mouse plasma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALYSIS TIME;
ANALYTICAL METHODOLOGY;
ANTI-CANCER AGENTS;
ANTICANCER DRUG;
BIOLOGICAL BINDING;
BLOOD PLASMA;
BLOOD SAMPLES;
CAPILLARY ZONE ELECTROPHORESIS;
CLINICAL TRIAL;
IN-VIVO;
IN-VIVO ANALYSIS;
INDAZOLE;
MODE OF ACTION;
MOUSE PLASMA;
PROTEIN BINDING;
RUTHENATES;
SAMPLE CONSUMPTION;
SERUM PROTEINS;
SIZE EXCLUSION;
TIME POINTS;
UNTREATED CONTROL;
BIOCHEMISTRY;
BLOOD;
CAPILLARY ELECTROPHORESIS;
INDUCTIVELY COUPLED PLASMA;
MASS SPECTROMETERS;
MASS SPECTROMETRY;
PROTEINS;
RUTHENIUM;
RUTHENIUM COMPOUNDS;
SODIUM;
STOICHIOMETRY;
MAMMALS;
ALBUMIN;
ANTINEOPLASTIC AGENT;
KP 1339;
SODIUM TRANS[TETRACHLORIDOBIS(1H INDAZOLE)RUTHENATE(III)];
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANION EXCHANGE CHROMATOGRAPHY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CAPILLARY ZONE ELECTROPHORESIS;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG PROTEIN BINDING;
GEL PERMEATION CHROMATOGRAPHY;
IN VIVO STUDY;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
STOICHIOMETRY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CHROMATOGRAPHY, GEL;
ELECTROPHORESIS, CAPILLARY;
INDAZOLES;
LIMIT OF DETECTION;
MASS SPECTROMETRY;
MICE;
ORGANOMETALLIC COMPOUNDS;
PROTEIN BINDING;
RUTHENIUM;
SERUM ALBUMIN;
MUS;
|
EID: 80053597770
PISSN: 17565901
EISSN: 1756591X
Source Type: Journal
DOI: 10.1039/c1mt00055a Document Type: Article |
Times cited : (58)
|
References (49)
|